There is something a little paradoxical about phentermine: it is a medication that helps you lose weight, and it can also cause insomnia which, if left unmanaged, can undermine the very weight loss it is supposed to support
This medication acts as a dual agonist, targeting both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor
Although GI AEs are common across all GLP-1 RAs, differences in formulation, dosing, and dual agonism with tirzepatide can influence how well patients tolerate therapy
authors reported employment/equity interests in the sponsor
According to Lambert, legitimate compounding pharmacies will have testing and verification for raw ingredients or APIs
When will TRIUMPH-1 publish